1-7 of 7
Richard J. Jones
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract NT-107: CHEMORESISTANT OVARIAN CANCER STEM CELLS REVEAL NOVEL THERAPEUTIC TARGETS

Free
Allison C. Sharrow, Richard J Jones, Lily Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): NT-107.
https://doi.org/10.1158/1557-3265.OVCASYMP18-NT-107
Published: 15 November 2019
View articletitled, Abstract NT-107: CHEMORESISTANT OVARIAN CANCER STEM CELLS REVEAL NOVEL THERAPEUTIC TARGETS
Journal Articles

Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191

Free
Haiwen Ni, Fazal Shirazi, Veerabhadran Baladandayuthapani, Heather Lin, Isere Kuiatse, Hua Wang, Richard J. Jones, Zuzana Berkova, Yasumichi Hitoshi, Stephen M. Ansell, Steven P. Treon, Sheeba K. Thomas, Hans C. Lee, Zhiqiang Wang, R. Eric Davis, Robert Z. Orlowski
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (24): 6408–6420.
https://doi.org/10.1158/1078-0432.CCR-17-3265
Published: 13 December 2018
View articletitled, Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191
Open the PDF for Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191 in another window
Includes: Supplementary data
Journal Articles

Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein–Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression

Free
Richard J. Jones, Tawin Iempridee, Xiaobin Wang, Hans C. Lee, Janet E. Mertz, Shannon C. Kenney, Heather C. Lin, Veerabhadran Baladandayuthapani, Christopher W. Dawson, Jatin J. Shah, Donna M. Weber, Robert Z. Orlowski
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (19): 4901–4912.
https://doi.org/10.1158/1078-0432.CCR-15-2242
Published: 02 October 2016
View articletitled, Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein–Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression
Open the PDF for Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein–Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression in another window
Includes: Supplementary data
Journal Articles

Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia

Free
Isere Kuiatse, Veerabhadran Baladandayuthapani, Heather Y. Lin, Sheeba K. Thomas, Chad C. Bjorklund, Donna M. Weber, Michael Wang, Jatin J. Shah, Xing-Ding Zhang, Richard J. Jones, Stephen M. Ansell, Guang Yang, Steven P. Treon, Robert Z. Orlowski
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (11): 2538–2545.
https://doi.org/10.1158/1078-0432.CCR-14-1462
Published: 31 May 2015
View articletitled, Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia
Open the PDF for Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia in another window
Includes: Supplementary data
Journal Articles

Novel Oligoamine Analogues Inhibit Lysine-Specific Demethylase 1 and Induce Reexpression of Epigenetically Silenced Genes

Free
Yi Huang, Tracy Murray Stewart, Yu Wu, Stephen B. Baylin, Laurence J. Marton, Brandy Perkins, Richard J. Jones, Patrick M. Woster, Robert A. Casero, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7217–7228.
https://doi.org/10.1158/1078-0432.CCR-09-1293
Published: 30 November 2009
View articletitled, Novel Oligoamine Analogues Inhibit Lysine-Specific Demethylase 1 and Induce Reexpression of Epigenetically Silenced Genes
Open the PDF for Novel Oligoamine Analogues Inhibit Lysine-Specific Demethylase 1 and Induce Reexpression of Epigenetically Silenced Genes in another window
Includes: Supplementary data
Journal Articles

Inhibition of the p53 E3 Ligase HDM-2 Induces Apoptosis and DNA Damage–Independent p53 Phosphorylation in Mantle Cell Lymphoma

Free
Richard J. Jones, Qing Chen, Peter M. Voorhees, Ken H. Young, Nathalie Bruey-Sedano, Dajun Yang, Robert Z. Orlowski
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (17): 5416–5425.
https://doi.org/10.1158/1078-0432.CCR-08-0150
Published: 02 September 2008
View articletitled, Inhibition of the p53 E3 Ligase HDM-2 Induces Apoptosis and DNA Damage–Independent p53 Phosphorylation in Mantle Cell Lymphoma
Open the PDF for Inhibition of the p53 E3 Ligase HDM-2 Induces Apoptosis and DNA Damage–Independent p53 Phosphorylation in Mantle Cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Sequential Flavopiridol, Cytosine Arabinoside, and Mitoxantrone: A Phase II Trial in Adults with Poor-Risk Acute Myelogenous Leukemia

Free
Judith E. Karp, B. Douglas Smith, Mark J. Levis, Steven D. Gore, Jacqueline Greer, Catherine Hattenburg, Janet Briel, Richard J. Jones, John J. Wright, A. Dimitri Colevas
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4467–4473.
https://doi.org/10.1158/1078-0432.CCR-07-0381
Published: 01 August 2007
View articletitled, Sequential Flavopiridol, Cytosine Arabinoside, and Mitoxantrone: A Phase II Trial in Adults with Poor-Risk Acute Myelogenous Leukemia
Open the PDF for Sequential Flavopiridol, Cytosine Arabinoside, and Mitoxantrone: A Phase II Trial in Adults with Poor-Risk Acute Myelogenous Leukemia in another window